Mr Ben Turney
Consultant Urological Surgeon
- General urology
- Urinary tract stones
- Urological oncology
Training & Background
- Qualifications: MA MB BChir MSc DPhil FRCS (Urol) PGDipLATHE
- Year first qualified: 1999
- GMC number: 4583888
Ben was an undergraduate in Cambridge and undertook surgical training in the Oxford region. He has completed research for both an MSc and DPhil (= PhD) in Oxford. He also obtained a diploma in university-level teaching in 2006 from the University of Oxford.
Ben’s clinical interests are in kidney stones and new treatments for benign prostate enlargement (BPH). Ben has driven successful business plans to introduce a fixed site lithotripter in Oxford (2009) and more recently (2012) a 100W laser for stone surgery and laser prostate surgery (HOLEP). A further successful business plan will allow expansion of the lithotripsy service to 5 full days a week. Ben drove the successful application to host international EBU fellowships in Oxford.
Ben’s research interest is in kidney stone disease and he has collaborations with genetics, mathematical modelling, biomedical engineering, public health and epidemiology departments in Oxford. Work from his research is presented regularly at international meetings and published in peer-reviewed journals. He is invited regularly to give presentations at national and international meetings.
Ben also has a research interest in surgical technology and digital healthcare. He is working with industry partners in IT (Oneview), technology and simulation (Boston Scientific) and 3D printing (3D lifeprints) to develop better technology and IT solutions for the future.
Ben has benefited from international experience with recognised leaders in the field including Prof Glenn Preminger at Duke University, North Carolina, USA, and Prof Olivier Traxer, Hôpital Tenon, Paris. In 2013, Ben was awarded the International Guest Scholarship of the American College of Surgeons, one of only 13 awarded internationally.
Research & Teaching
Mr Turney’s main research interest is in kidney stone disease. Ben established and leads the Oxford Stone Group and he has active collaborations with proteomics, genetics, biomedical engineering, mathematics, public health and epidemiology departments in Oxford. To support this research Ben has established a biobank of over 800 stone patients using funds obtained from the Oxford Biomedical Research Centre.
More recently, Ben has become involved with a collaboration with McLaren Applied Technologies, part of the McLaren F1 group, to develop new technology in healthcare. This includes activity monitoring to assess patient fitness and new electronic patient pathways.
Work from his research is presented regularly in international meetings and published in peer-reviewed journals. He has given invited presentations at national and international meetings.
- Royal College of Surgeons of England
- British Association of Urological Surgeons
- BAUS Section of Endourology